Yayın:
The outcome of patients with Hodgkin lymphoma and early relapse after autologous stem cell transplant has improved in recent years

Sadeleştirilmiş öğe sayfası
dc.contributor.authorGülbaş, Zafer
dc.contributor.authorAriane Boumendil
dc.contributor.authorHervé Finel
dc.contributor.authorIrma Khvedelidze
dc.contributor.authorJoanna Romejko‐Jarosińska
dc.contributor.authorAlina Tănase
dc.contributor.authorSaad Akhtar
dc.contributor.authorTarek Ben Othman
dc.contributor.authorMohammad Ma’koseh
dc.contributor.authorBoris V. Afanasyev
dc.contributor.authorJean El Cheikh
dc.contributor.authorJavier Briones
dc.contributor.authorZafer Gülbaş
dc.contributor.authorRose‐Marie Hamladji
dc.contributor.authorTuğrul Elverdi
dc.contributor.authorDidier Blaise
dc.contributor.authorCarmen Martı́nez
dc.contributor.authorEleonora Alma
dc.contributor.authorKazimierz Hałaburda
dc.contributor.authorAïda Botelho de Sousa
dc.contributor.authorBertram Glaß
dc.contributor.authorSteven E. Robinson
dc.contributor.authorSilvia Montoto
dc.contributor.authorAnna Sureda
dc.contributor.orcid0000-0002-7171-4997
dc.contributor.orcid0000-0002-2552-0542
dc.contributor.orcid0000-0002-0432-9765
dc.contributor.orcid0000-0003-4603-1112
dc.contributor.orcid0000-0003-3075-499X
dc.contributor.orcid0000-0002-4294-0944
dc.contributor.orcid0000-0002-1235-4530
dc.contributor.orcid0000-0003-2846-9428
dc.contributor.orcid0000-0003-2750-3735
dc.contributor.orcid0000-0002-4709-0627
dc.contributor.orcid0000-0001-9496-5353
dc.contributor.orcid0000-0002-5684-9447
dc.contributor.orcid0000-0002-8401-7306
dc.contributor.orcid0000-0001-7008-3313
dc.contributor.orcid0000-0003-3624-785X
dc.contributor.orcid0009-0000-0816-688X
dc.contributor.orcid0000-0002-3006-9725
dc.contributor.orcid0000-0002-1238-6970
dc.date.accessioned2025-11-13T10:46:10Z
dc.date.issued2022-04-12
dc.identifier.doihttps://doi.org/10.1038/s41375-022-01563-8
dc.identifier.endpage1653
dc.identifier.issn0887-6924
dc.identifier.issue6
dc.identifier.openalexW4223484507
dc.identifier.startpage1646
dc.identifier.urihttps://hdl.handle.net/11421/5202
dc.identifier.urihttps://doi.org/10.1038/s41375-022-01563-8
dc.identifier.volume36
dc.language.isoen
dc.relation.ispartofLeukemia
dc.rightsrestrictedAccess
dc.subjectMedicine
dc.subjectInternal medicine
dc.subjectBrentuximab vedotin
dc.subjectLymphoma
dc.subjectTransplantation
dc.subjectOncology
dc.subjectMultivariate analysis
dc.subjectDisease
dc.subjectStem cell
dc.subjectHematopoietic stem cell transplantation
dc.subjectHodgkin lymphoma
dc.subject.sdg1
dc.titleThe outcome of patients with Hodgkin lymphoma and early relapse after autologous stem cell transplant has improved in recent years
dc.typeArticle
dspace.entity.typePublication
local.authorid.openalexA5058571002

Dosyalar

Koleksiyonlar

Publications